CrossRef

Unlocking Performance: Pharmacogenomic Insights for Athletes

Sports Medicine International Open 10(CP) (2026)

Kristal S. Potter; Jessica Beal-Stahl; Megan Luaces; Kevin Chin; Anam F. Ismail; Courtney Guerra

Codeine Precipitating Serotonin Syndrome in a Patient in Therapy with Antidepressant and Triptan

Clinical Psychopharmacology and Neuroscience 15(3) (2017)

Giulia Milano; Werner Maria Natta; Alfredo Bello; Antonietta Martelli; Francesca Mattioli

Effect of non‐prohibited drugs on the phase II metabolic profile of morphine. An in vitro investigation for doping control purposes

Drug Testing and Analysis 10(6) (2018)

Gabriella Ambrosio; Xavier de la Torre; Monica Mazzarino; Maria K. Parr; Francesco Botrè

Intra‐Individual Variability of Blood and Urinary Steroid Markers and the Response to Codeine Intake in Healthy Men and Women

Drug Testing and Analysis (2026)

Alexander Andersson; Basam Yousif; Anton Pohanka; Annica Börjesson; Mikael Lehtihet; Lena Ekström

Codeine influences the serum and urinary profile of endogenous androgens but does not interact with the excretion rate of administered testosterone

Drug Testing and Analysis 10(4) (2018)

M. Lehtihet; A. Andersson; A. Börjesson; J. Schulze; A. Rane; M. Ericsson; L. Ekström

Case Report: A case study of positive doping control by animal-to-human drug transfer after an athlete administered medicine in spray format, containing clostebol acetate, to a pet dog

Frontiers in Sports and Active Living 6 (2024)

Andrzej Pokrywka; Dariusz Sitkowski; Olga Surała; Laurie Gheddar; Pascal Kintz

Annual banned‐substance review: analytical approaches in human sports drug testing

Drug Testing and Analysis 9(1) (2017)

Mario Thevis; Tiia Kuuranne; Hans Geyer; Wilhelm Schänzer

Mass Spectrometry-Based Anti-Doping Analysis: A Critical Review of Emerging Analytical and Sample Pretreatment Strategies

Critical Reviews in Analytical Chemistry (2026)

Dnyaneshwar Maykar; Pratik Vilas Gore; Suraj R. Chaudhari; Pramod Kumar

A hierarchical 3D camellia-like molybdenum tungsten disulfide architectures for the determination of morphine and tramadol

Microchimica Acta 187(5) (2020)

Somayeh Mohammadi; Mohammad Ali Taher; Hadi Beitollahi

Untitled

Comprehensive analysis of prohibited substances and methods in sports: Unveiling trends, pharmacokinetics, and WADA evolution

Environmental Toxicology and Pharmacology 108 (2024)

Patrik Oleksak; Eugenie Nepovimova; Marian Valko; Saleh Alwasel; Suliman Alomar; Kamil Kuca

Untitled

Codeine and Tramadol Use in Athletes: A Potential for Abuse

Frontiers in Pharmacology 12 (2021)

Thomas Zandonai; Mónica Escorial; Ana M. Peiró

Anaesthesia for elite athletes

European Journal of Anaesthesiology 39(10) (2022)

Bram Bourgonjon; Kris Vermeylen; Niek Tytgat; Patrice Forget

Integrating pharmacogenetics in sport medicine: enhancing treatment precision and preventing unintentional doping violation

Pharmacogenetics and Genomics 35(5) (2025)

Guillaume Drevin; Marie Briet; Chadi Abbara

Unravelling the threat of contamination in elite sports: Exploring diverse sources impacting adverse analytical findings and the risk of inadvertent exposure to prohibited substances

Forensic Science International 365 (2024)

Ana Belen Moraleda Merlo; Louisa Lobigs; Thomas Piper; Christophe Champod; Neil Robinson

Morphine/codéine dans les urines de sportifs : quels ratios au cours des contrôles demandés par l’Agence française de lutte contre le dopage (AFLD) ?

Toxicologie Analytique et Clinique 28(2) (2016)

N. Méchin; E. Cerpolini; M. Conjeaud; M. Fernandes; A. Molina; A. Coquerel